Pandemic panic and indiscriminate prescriptions drive India’s antimicrobial resistance

  10 March 2022

Indiscriminate prescriptions during the pandemic are accelerating the crisis of antimicrobial resistance in a country that already had the world’s largest consumption of antibiotics, reports Kamala Thiagarajan

There’s a stark difference in how high and middle to low income countries have been dealing with antibiotic use during the pandemic, says Sumanth Gandra, infectious disease specialist and associate professor at Washington University School of Medicine in the United States.

In the initial month after the pandemic began in January 2020, healthcare workers in high income countries were growing increasingly concerned about the cases of pneumonia they were seeing among patients with covid-19 and the high risk of secondary bacterial infection. “Antibiotics were given to everyone who was hospitalized in the US at this time,” Gandra says. But medical practitioners soon realised that these secondary infections weren’t quite as common as previously assumed and so the practice swiftly ended. “There was an uptick in the first month and then a huge drop in antibiotic sales, especially over the lockdown phases,” says Gandra.

Further reading: theBMJ
Author(s): Kamala Thiagarajan
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!